Abe, N, Uchida, S, Otsuki, K, Hobara, T, Yamagata, H, Higuchi, F, Shibata, T and Watanabe, Y (2011) Altered sirtuin deacetylase gene expression in patients with a mood disorder. Journal of Psychiatric Research 45, 1106–1112.
Agudelo, LZ, Femenia, T, Orhan, F, Porsmyr-Palmertz, M, Goiny, M, Martinez-Redondo, V, Correia, JC, Izadi, M, Bhat, M, Schuppe-Koistinen, I, Pettersson, AT, Ferreira, DMS, Krook, A, Barres, R, Zierath, JR, Erhardt, S, Lindskog, M and Ruas, JL (2014) Skeletal muscle PGC-1alpha1 modulates kynurenine metabolism and mediates resilience to stress-induced depression. Cell 159, 33–45.
Aguirre-Rueda, D, Guerra-Ojeda, S, Aldasoro, M, Iradi, A, Obrador, E, Ortega, A, Mauricio, MD, Vila, JM and Valles, SL (2015) Astrocytes protect neurons from Abeta1-42 peptide-induced neurotoxicity increasing TFAM and PGC-1 and decreasing PPAR-gamma and SIRT-1. International Journal of Medical Sciences 12, 48–56.
Als, TD, Dahl, HA, Flint, TJ, Wang, AG, Vang, M, Mors, O, Kruse, TA and Ewald, H (2004) Possible evidence for a common risk locus for bipolar affective disorder and schizophrenia on chromosome 4p16 in patients from the Faroe Islands. Molecular Psychiatry 9, 93–98.
Arany, Z, Foo, SY, Ma, Y, Ruas, JL, Bommi-Reddy, A, Girnun, G, Cooper, M, Laznik, D, Chinsomboon, J, Rangwala, SM, Baek, KH, Rosenzweig, A and Spiegelman, BM (2008) HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature 451, 1008–1012.
Beckham, EE and Leber, WR (1985) Hamilton Rating Scale for Depression, ECDEU Version Used in the Treatment of Depression Collaborative Research Program. Homewood: The Dorsey Press.
Berlim, MT, Van den Eynde, F and Daskalakis, ZJ (2013) Efficacy and acceptability of high frequency repetitive transcranial magnetic stimulation (rTMS) versus electroconvulsive therapy (ECT) for major depression: a systematic review and meta-analysis of randomized trials. Depression and Anxiety 30, 614–623.
Blackwood, DH, He, L, Morris, SW, McLean, A, Whitton, C, Thomson, M, Walker, MT, Woodburn, K, Sharp, CM, Wright, AF, Shibasaki, Y, St Clair, DM, Porteous, DJ and Muir, WJ (1996) A locus for bipolar affective disorder on chromosome 4p. Nature Genetics 12, 427–430.
Buler, M, Aatsinki, SM, Skoumal, R, Komka, Z, Toth, M, Kerkela, R, Georgiadi, A, Kersten, S and Hakkol, J (2012) Energy-sensing factors coactivator peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1alpha) and AMP-activated protein kinase control expression of inflammatory mediators in liver: induction of interleukin 1 receptor antagonist. Journal of Biological Chemistry 287, 1847–1860.
Burigo, M, Roza, CA, Bassani, C, Fagundes, DA, Rezin, GT, Feier, G, Dal-Pizzol, F, Quevedo, J and Streck, EL (2006) Effect of electroconvulsive shock on mitochondrial respiratory chain in rat brain. Neurochemical Research 31, 1375–1379.
Carvalho, AF, Kohler, CA, McIntyre, RS, Knochel, C, Brunoni, AR, Thase, ME, Quevedo, J, Fernandes, BS and Berk, M (2015) Peripheral vascular endothelial growth factor as a novel depression biomarker: a meta-analysis. Psychoneuroendocrinology 62, 18–26.
Chang, HC and Guarente, L (2013) SIRT1 mediates central circadian control in the SCN by a mechanism that decays with aging. Cell 153, 1448–1460.
Chang, CC, Jou, SH, Lin, TT, Lai, TJ and Liu, CS (2015) Mitochondria DNA change and oxidative damage in clinically stable patients with major depressive disorder. PLoS One 10, e0125855.
Christoforou, A, Le Hellard, S, Thomson, PA, Morris, SW, Tenesa, A, Pickard, BS, Wray, NR, Muir, WJ, Blackwood, DH, Porteous, DJ and Evans, KL (2007) Association analysis of the chromosome 4p15-p16 candidate region for bipolar disorder and schizophrenia. Molecular Psychiatry 12, 1011–1025.
Ciron, C, Lengacher, S, Dusonchet, J, Aebischer, P and Schneider, BL (2012) Sustained expression of PGC-1alpha in the rat nigrostriatal system selectively impairs dopaminergic function. Human Molecular Genetics 21, 1861–1876.
Clark, J, Reddy, S, Zheng, K, Betensky, RA and Simon, DK (2011) Association of PGC-1alpha polymorphisms with age of onset and risk of Parkinson's disease. BMC Medical Genetics 12, 69.
Clark, J, Silvaggi, JM, Kiselak, T, Zheng, K, Clore, EL, Dai, Y, Bass, CE and Simon, DK (2012) Pgc-1alpha overexpression downregulates Pitx3 and increases susceptibility to MPTP toxicity associated with decreased Bdnf. PLoS One 7, e48925.
Cobb, JA, O'Neill, K, Milner, J, Mahajan, GJ, Lawrence, TJ, May, WL, Miguel-Hidalgo, J, Rajkowska, G and Stockmeier, CA (2016) Density of GFAP-immunoreactive astrocytes is decreased in left hippocampi in major depressive disorder. Neuroscience 316, 209–220.
Coppen, A (1967) The biochemistry of affective disorders. British Journal of Psychiatry 113, 1237–1264.
Cowell, RM, Blake, KR and Russell, JW (2007) Localization of the transcriptional coactivator PGC-1alpha to GABAergic neurons during maturation of the rat brain. Journal of Comparative Neurology 502, 1–18.
Dougherty, SE, Bartley, AF, Lucas, EK, Hablitz, JJ, Dobrunz, LE and Cowell, RM (2014) Mice lacking the transcriptional coactivator PGC-1alpha exhibit alterations in inhibitory synaptic transmission in the motor cortex. Neuroscience 271, 137–148.
Dowlati, Y, Herrmann, N, Swardfager, W, Liu, H, Sham, L, Reim, EK and Lanctot, KL (2010) A meta-analysis of cytokines in major depression. Biological Psychiatry 67, 446–457.
Duman, RS and Vaidya, VA (1998) Molecular and cellular actions of chronic electroconvulsive seizures. Journal of ECT 14, 181–193.
Esterbauer, H, Oberkofler, H, Krempler, F and Patsch, W (1999) Human peroxisome proliferator activated receptor gamma coactivator 1 (PPARGC1) gene: cDNA sequence, genomic organization, chromosomal localization, and tissue expression. Genomics 62, 98–102.
Fernandez-Marcos, PJ and Auwerx, J (2011) Regulation of PGC-1alpha, a nodal regulator of mitochondrial biogenesis. The American Journal of Clinical Nutrition 93, 884S–890S.
First, M, Spitzer, R, Gibbon, M and Williams, J (1996) Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). Washington, DC: American Psychiatric Press.
Friedrich, MJ (2017) Depression is the leading cause of disability around the world. JAMA 317, 1517.
Gardner, A and Boles, RG (2011) Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders. Progress in Neuropsychopharmacology and Biological Psychiatry 35, 730–743.
Garlanda, C, Dinarello, CA and Mantovani, A (2013) The interleukin-1 family: back to the future. Immunity 39, 1003–1018.
Geoffroy, PA, Etain, B, Lajnef, M, Zerdazi, EH, Brichant-Petitjean, C, Heilbronner, U, Hou, L, Degenhardt, F, Rietschel, M, McMahon, FJ, Schulze, TG, Jamain, S, Marie-Claire, C and Bellivier, F (2016) Circadian genes and lithium response in bipolar disorders: associations with PPARGC1A (PGC-1alpha) and RORA. Genes, Brain and Behavior 15, 660–668.
Glombik, K, Stachowicz, A, Slusarczyk, J, Trojan, E, Budziszewska, B, Suski, M, Kubera, M, Lason, W, Wedzony, K, Olszanecki, R and Basta-Kaim, A (2015) Maternal stress predicts altered biogenesis and the profile of mitochondrial proteins in the frontal cortex and hippocampus of adult offspring rats. Psychoneuroendocrinology 60, 151–162.
Guloksuz, S, Arts, B, Walter, S, Drukker, M, Rodriguez, L, Myint, AM, Schwarz, MJ, Ponds, R, van Os, J, Kenis, G and Rutten, BP (2015) The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway. Brain Behaviour and Immunity 48, 48–52.
Harkin, A (2014) Muscling in on depression. New England Journal of Medicine 371, 2333–2334.
Howren, MB, Lamkin, DM and Suls, J (2009) Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosomatic Medicine 71, 171–186.
Jang, WG, Kim, EJ, Park, KG, Park, YB, Choi, HS, Kim, HJ, Kim, YD, Kim, KS, Lee, KU and Lee, IK (2007) Glucocorticoid receptor mediated repression of human insulin gene expression is regulated by PGC-1alpha. Biochemical and Biophysical Research Communication 352, 716–721.
Jarventausta, K, Sorri, A, Kampman, O, Bjorkqvist, M, Tuohimaa, K, Hamalainen, M, Moilanen, E, Leinonen, E, Peltola, J and Lehtimaki, K (2017) Changes in interleukin-6 levels during electroconvulsive therapy may reflect the therapeutic response in major depression. Acta Psychiatrica Scandinavica 135, 87–92.
Jeong, J, Park, M, Yoon, JS, Kim, H, Lee, SK, Lee, E, Namkoong, K and Kim, E (2015) Requirement of AMPK activation for neuronal metabolic-enhancing effects of antidepressant paroxetine. Neuroreport 26, 424–428.
Jiang, H, Kang, SU, Zhang, S, Karuppagounder, S, Xu, J, Lee, YK, Kang, BG, Lee, Y, Zhang, J, Pletnikova, O, Troncoso, JC, Pirooznia, S, Andrabi, SA, Dawson, VL and Dawson, TM (2016) Adult conditional knockout of PGC-1alpha leads to loss of dopamine neurons. eNeuro 3(4), e0183-16.2016 1–8.
Kang, HJ, Voleti, B, Hajszan, T, Rajkowska, G, Stockmeier, CA, Licznerski, P, Lepack, A, Majik, MS, Jeong, LS, Banasr, M, Son, H and Duman, RS (2012) Decreased expression of synapse-related genes and loss of synapses in major depressive disorder. Nature Medicine 18, 1413–1417.
Karabatsiakis, A, Bock, C, Salinas-Manrique, J, Kolassa, S, Calzia, E, Dietrich, DE and Kolassa, IT (2014) Mitochondrial respiration in peripheral blood mononuclear cells correlates with depressive subsymptoms and severity of major depression. Translational Psychiatry 4, e397.
Kato, N (2009) Neurophysiological mechanisms of electroconvulsive therapy for depression. Neuroscience Research 64, 3–11.
Kendler, KS, Neale, MC, MacLean, CJ, Heath, AC, Eaves, LJ and Kessler, RC (1993) Smoking and major depression. A causal analysis. Archives of General Psychiatry 50, 36–43.
Khalaj, L, Nejad, SC, Mohammadi, M, Zadeh, SS, Pour, MH, Ahmadiani, A, Khodagholi, F, Ashabi, G, Alamdary, SZ and Samami, E (2013) Gemfibrozil pretreatment proved protection against acute restraint stress-induced changes in the male rats' hippocampus. Brain Research 1527, 117–130.
Kim, MS, Sweeney, TR, Shigenaga, JK, Chui, LG, Moser, A, Grunfeld, C and Feingold, KR (2007) Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells. Metabolism 56, 267–279.
Kim, SH, Koh, JH, Higashida, K, Jung, SR, Holloszy, JO and Han, DH (2015) PGC-1alpha mediates a rapid, exercise-induced downregulation of glycogenolysis in rat skeletal muscle. The Journal of Physiology 593, 635–643.
Klinedinst, NJ and Regenold, WT (2015) A mitochondrial bioenergetic basis of depression. Journal of Bioenergetics and Biomembranes 47, 155–171.
Kolshus, E, Ryan, KM, Blackshields, G, Smyth, P, Sheils, O and McLoughlin, DM (2017) Peripheral blood microRNA and VEGFA mRNA changes following electroconvulsive therapy: implications for psychotic depression. Acta Psychiatrica Scandinavica 136, 594–606.
Labuzek, K, Liber, S, Gabryel, B and Okopien, B (2010) AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) increases the production of toxic molecules and affects the profile of cytokines release in LPS-stimulated rat primary microglial cultures. Neurotoxicology 31, 134–146.
Liang, H and Ward, WF (2006) PGC-1alpha: a key regulator of energy metabolism. Advances in Physiology Education 30, 145–151.
Lin, PY and Tseng, PT (2015) Decreased glial cell line-derived neurotrophic factor levels in patients with depression: a meta-analytic study. Journal of Psychiatric Research 63, 20–27.
Lin, J, Wu, PH, Tarr, PT, Lindenberg, KS, St-Pierre, J, Zhang, CY, Mootha, VK, Jager, S, Vianna, CR, Reznick, RM, Cui, L, Manieri, M, Donovan, MX, Wu, Z, Cooper, MP, Fan, MC, Rohas, LM, Zavacki, AM, Cinti, S, Shulman, GI, Lowell, BB, Krainc, D and Spiegelman, BM (2004) Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 119, 121–135.
Lin, JD, Liu, C and Li, S (2008) Integration of energy metabolism and the mammalian clock. Cell Cycle 7, 453–457.
Livak, KJ and Schmittgen, TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402–408.
Luo, XJ and Zhang, C (2016) Down-regulation of SIRT1 gene expression in major depressive disorder. The American Journal of Psychiatry 173, 1046.
Mootha, VK, Lindgren, CM, Eriksson, KF, Subramanian, A, Sihag, S, Lehar, J, Puigserver, P, Carlsson, E, Ridderstrale, M, Laurila, E, Houstis, N, Daly, MJ, Patterson, N, Mesirov, JP, Golub, TR, Tamayo, P, Spiegelman, B, Lander, ES, Hirschhorn, JN, Altshuler, D and Groop, LC (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nature Genetics 34, 267–273.
Muller, N and Schwarz, MJ (2007) The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Molecular Psychiatry 12, 988–1000.
Nierenberg, AA, Ghaznavi, SA, Mathias, IS, Ellard, KK, Janos, JA and Sylvia, LG (2018) Peroxisome proliferator activated receptor gamma co-activator-1 alpha as a novel target for bipolar disorder and other neuropsychiatric disorders. Biological Psychiatry 83, 761–769.
Nijland, PG, Witte, ME, van het Hof, B, van der Pol, S, Bauer, J, Lassmann, H, van der Valk, P, de Vries, HE and van Horssen, J (2014) Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis. Acta Neuropathologica Communications 2, 170.
Ogyu, K, Kubo, K, Noda, Y, Iwata, Y, Tsugawa, S, Omura, Y, Wada, M, Tarumi, R, Plitman, E, Moriguchi, S, Miyazaki, T, Uchida, H, Graff-Guerrero, A, Mimura, M and Nakajima, S (2018) Kynurenine pathway in depression: a systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews 90, 16–25.
Polyakova, M, Schroeter, ML, Elzinga, BM, Holiga, S, Schoenknecht, P, de Kloet, ER and Molendijk, ML (2015) Brain-derived neurotrophic factor and antidepressive effect of electroconvulsive therapy: systematic review and meta-analyses of the preclinical and clinical literature. PLoS One 10, e0141564.
Puigserver, P, Wu, Z, Park, CW, Graves, R, Wright, M and Spiegelman, BM (1998) A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92, 829–839.
Puigserver, P, Rhee, J, Donovan, J, Walkey, CJ, Yoon, JC, Oriente, F, Kitamura, Y, Altomonte, J, Dong, H, Accili, D and Spiegelman, BM (2003) Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 423, 550–555.
Qin, W, Haroutunian, V, Katsel, P, Cardozo, CP, Ho, L, Buxbaum, JD and Pasinetti, GM (2009) PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia. Archives of Neurology 66, 352–361.
Rodgers, JT, Lerin, C, Haas, W, Gygi, SP, Spiegelman, BM and Puigserver, P (2005) Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434, 113–118.
Ryan, KM, Glaviano, A, O'Donovan, SM, Kolshus, E, Dunne, R, Kavanagh, A, Jelovac, A, Noone, M, Tucker, GM, Dunn, MJ and McLoughlin, DM (2017) Electroconvulsive therapy modulates plasma pigment epithelium-derived factor in depression: a proteomics study. Translational Psychiatry 7, e1073.
Rytinki, MM and Palvimo, JJ (2009) SUMOylation attenuates the function of PGC-1alpha. The Journal of Biological Chemistry 284, 26184–26193.
Sajan, MP, Ivey, RA and Farese, RV (2015) BMI-related progression of atypical PKC-dependent aberrations in insulin signaling through IRS-1, Akt, FoxO1 and PGC-1alpha in livers of obese and type 2 diabetic humans. Metabolism 64, 1454–1465.
Schosser, A, Gaysina, D, Cohen-Woods, S, Domenici, E, Perry, J, Tozzi, F, Korszun, A, Gunasinghe, C, Gray, J, Jones, L, Binder, EB, Holsboer, F, Craddock, N, Owen, MJ, Craig, IW, Farmer, AE, Muglia, P and McGuffin, P (2011) A follow-up case-control association study of tractable (druggable) genes in recurrent major depression. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 156B, 640–650.
Schuch, JB, Genro, JP, Bastos, CR, Ghisleni, G and Tovo-Rodrigues, L (2017) The role of CLOCK gene in psychiatric disorders: evidence from human and animal research. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 177, 181–198.
Schwieler, L, Samuelsson, M, Frye, MA, Bhat, M, Schuppe-Koistinen, I, Jungholm, O, Johansson, AG, Landen, M, Sellgren, CM and Erhardt, S (2016) Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients. Journal of Neuroinflammation 13, 51.
Semkovska, M, Landau, S, Dunne, R, Kolshus, E, Kavanagh, A, Jelovac, A, Noone, M, Carton, M, Lambe, S, McHugh, C and McLoughlin, DM (2016) Bitemporal versus high-dose unilateral twice-weekly electroconvulsive therapy for depression (EFFECT-Dep): a pragmatic, randomized, non-inferiority trial. The American Journal of Psychiatry 173, 408–417.
Simon, GE, Von Korff, M, Saunders, K, Miglioretti, DL, Crane, PK, van Belle, G and Kessler, RC (2006) Association between obesity and psychiatric disorders in the US adult population. Archives of General Psychiatry 63, 824–830.
Soyal, SM, Felder, TK, Auer, S, Hahne, P, Oberkofler, H, Witting, A, Paulmichl, M, Landwehrmeyer, GB, Weydt, P, Patsch, W and European Huntington Disease Network (2012) A greatly extended PPARGC1A genomic locus encodes several new brain-specific isoforms and influences Huntington disease age of onset. Human Molecular Genetics 21, 3461–3473.
St-Pierre, J, Drori, S, Uldry, M, Silvaggi, JM, Rhee, J, Jager, S, Handschin, C, Zheng, K, Lin, J, Yang, W, Simon, DK, Bachoo, R and Spiegelman, BM (2006) Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127, 397–408.
Sugden, MC, Caton, PW and Holness, MJ (2010) PPAR control: it's SIRTainly as easy as PGC. Journal of Endocrinology 204, 93–104.
Takacs, M, Petoukhov, MV, Atkinson, RA, Roblin, P, Ogi, FX, Demeler, B, Potier, N, Chebaro, Y, Dejaegere, A, Svergun, DI, Moras, D and Billas, IM (2013) The asymmetric binding of PGC-1alpha to the ERRalpha and ERRgamma nuclear receptor homodimers involves a similar recognition mechanism. PLoS One 8, e67810.
Tang, K, Wagner, PD and Breen, EC (2010) TNF-alpha-mediated reduction in PGC-1alpha may impair skeletal muscle function after cigarette smoke exposure. Journal of Cellular Physiology 222, 320–327.
Thau, N, Knippenberg, S, Korner, S, Rath, KJ, Dengler, R and Petri, S (2012) Decreased mRNA expression of PGC-1alpha and PGC-1alpha-regulated factors in the SOD1G93A ALS mouse model and in human sporadic ALS. Journal of Neuropathology and Experimental Neurology 71, 1064–1074.
Tritos, NA, Mastaitis, JW, Kokkotou, EG, Puigserver, P, Spiegelman, BM and Maratos-Flier, E (2003) Characterization of the peroxisome proliferator activated receptor coactivator 1 alpha (PGC 1alpha) expression in the murine brain. Brain Research 961, 255–260.
Tseng, PT, Cheng, YS, Chen, YW, Wu, CK and Lin, PY (2015) Increased levels of vascular endothelial growth factor in patients with major depressive disorder: a meta-analysis. European Neuropsychopharmacology 25, 1622–1630.
UK ECT Review Group (2003) Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 361, 799–808.
Vega, RB, Huss, JM and Kelly, DP (2000) The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Molecular and Cellular Biology 20, 1868–1876.
Villena, JA (2015) New insights into PGC-1 coactivators: redefining their role in the regulation of mitochondrial function and beyond. The FEBS Journal 282, 647–672.
Wang, Q and Dwivedi, Y (2017) Transcriptional profiling of mitochondria associated genes in prefrontal cortex of subjects with major depressive disorder. The World Journal of Biological Psychiatry 18, 592–603.
Weydt, P, Soyal, SM, Landwehrmeyer, GB, Patsch, W and European Huntington Disease Network (2014) A single nucleotide polymorphism in the coding region of PGC-1alpha is a male-specific modifier of Huntington disease age-at-onset in a large European cohort. BMC Neurology 14, 1.
World Medical Association (2013) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310, 2191–2194.
Yrondi, A, Sporer, M, Peran, P, Schmitt, L, Arbus, C and Sauvaget, A (2018) Electroconvulsive therapy, depression, the immune system and inflammation: a systematic review. Brain Stimulation 11, 29–51.
Zaki, NFW, Spence, DW, BaHammam, AS, Pandi-Perumal, SR, Cardinali, DP and Brown, GM (2017) Chronobiological theories of mood disorder. European Archives of Psychiatry and Clinical Neuroscience 268, 107–118.